AT434034T
Recombinant vascular endothelial cell growth factor D (VEGF-D)
Abstract
This record has no abstract on file.
Term
Term ended
Expired 21 August 2017, 9.1 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
56 members in 11 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 2375196 | United States of America | P | |
| PO182596 | Australia | A | |
| PO355496 | Australia | A | |
| 3109796 | United States of America | P | |
| PO495497 | Australia | A | |
| 3881497 | United States of America | P | |
| PO743597 | Australia | A | |
| 5142697 | United States of America | P |
Members56
| Document | Office | Kind | |
|---|---|---|---|
| CA2263890A1 | Canada | A1 | |
| WO9807832A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4079697A | Australia | A | |
| EP0956339A1 | European Patent Office (EPO) | A1 | |
| EP0956339A4 | European Patent Office (EPO) | A4 | |
| HK1025789A1 | Hong Kong, China | A1 | |
| AU729880B2 | Australia | B2 | |
| US6235713B1 | United States of America | B1 | |
| JP2001517075A | Japan | A | |
| AU729880C | Australia | C | |
| EP1283268A2 | European Patent Office (EPO) | A2 | |
| US2003114658A1 | United States of America | A1 | |
| US2003125537A1 | United States of America | A1 | |
| EP1283268A3 | European Patent Office (EPO) | A3 | |
| US6689580B1 | United States of America | B1 | |
| US2004175730A1 | United States of America | A1 | |
| EP0956339B1 | European Patent Office (EPO) | B1 | |
| AT306546T | Austria | T | |
| ATE306546T1 | Austria | T1 | |
| DK0956339T3 | Denmark | T3 | |
| DE69734359D1 | Germany | D1 | |
| ES2251740T3 | Spain | T3 | |
| DE69734359T2 | Germany | T2 | |
| US2006177428A1 | United States of America | A1 | |
| US7122654B2 | United States of America | B2 | |
| EP1749836A2 | European Patent Office (EPO) | A2 | |
| JP2007167072A | Japan | A | |
| EP1749836A3 | European Patent Office (EPO) | A3 | |
| US2007298493A1 | United States of America | A1 | |
| US2008058258A1 | United States of America | A1 | |
| US2008070831A1 | United States of America | A1 | |
| US2008145366A1 | United States of America | A1 | |
| US7410639B2 | United States of America | B2 | |
| US2009087905A1 | United States of America | A1 | |
| EP1749836B1 | European Patent Office (EPO) | B1 | |
| AT434034TThis record | Austria | T | |
| ATE434034T1 | Austria | T1 | |
| DE69739469D1 | Germany | D1 | |
| DK1749836T3 | Denmark | T3 | |
| EP2107109A1 | European Patent Office (EPO) | A1 | |
| ES2327440T3 | Spain | T3 | |
| JP2009291198A | Japan | A | |
| US7662932B2 | United States of America | B2 | |
| US7785803B2 | United States of America | B2 | |
| US7871798B2 | United States of America | B2 | |
| US7928061B2 | United States of America | B2 | |
| US2011281799A1 | United States of America | A1 | |
| EP2107109B1 | European Patent Office (EPO) | B1 | |
| US8227410B2 | United States of America | B2 | |
| DK2107109T3 | Denmark | T3 | |
| ES2390107T3 | Spain | T3 | |
| US2012322105A1 | United States of America | A1 | |
| CA2263890C | Canada | C | |
| US8445234B2 | United States of America | B2 | |
| US2013345409A1 | United States of America | A1 | |
| US8759286B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 6121918
Titles2
- German
- REKOMBINANTER VASCULÄRER ENDOTHELZELLEN WACHSTUMSFAKTOR D (VEGF-D)
- English
- RECOMBINANT VASCULAR ENDOTHELIAL CELL GROWTH FACTOR D (VEGF-D)
Classification
- CPC, 14
- C07K14/475
- A61K38/00
- A61P7/00
- C07K14/52
- A61P9/00
- A61P9/08
- A61P9/10
- A61P17/02
- A61P17/06
- A61P19/02
- A61P27/02
- A61P35/00
- A61P35/04
- A61P43/00
- IPC, 21
- C12N1 21
- C12N15 09
- A61K38 00
- A61K38 22
- A61K39 395
- A61K45 00
- A61K48 00
- A61P43 00
- C07K1 14
- C07K14 475
- C07K14 49
- C07K14 515
- C07K14 52
- C07K16 22
- C12N1 15
- C12N1 19
- C12N5 10
- C12N15 18
- C12N15 63
- C12P21 02
- C12P21 08